Price target upside
Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) Price Target Upside or Downside
SVA price target upside based on the current price and analyst average.
Direct answer
Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo)'s analyst target implies -45.6%.
The average target is $3.52 compared with a recorded current price of $6.47.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 12, 2026.
Get free Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.47
- Average price target
- $3.52
- High price target
- $6.00
- Low price target
- $1.50
- Target upside
- -45.6%
- Consensus rating
- Buy
- Analysts
- 6
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026